These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma. Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879 [TBL] [Abstract][Full Text] [Related]
8. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location. Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367 [TBL] [Abstract][Full Text] [Related]
9. Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma. Sun Y; Sun Y; Yan K; Li Z; Xu C; Geng Y; Pan C; Chen X; Zhang L; Xi Q EBioMedicine; 2019 May; 43():171-179. PubMed ID: 31060906 [TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma. Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822 [TBL] [Abstract][Full Text] [Related]
11. The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation. Roig-Carles D; Jackson H; Loveson KF; Mackay A; Mather RL; Waters E; Manzo M; Alborelli I; Golding J; Jones C; Fillmore HL; Crea F Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502082 [TBL] [Abstract][Full Text] [Related]
12. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Ahsan S; Raabe EH; Haffner MC; Vaghasia A; Warren KE; Quezado M; Ballester LY; Nazarian J; Eberhart CG; Rodriguez FJ Acta Neuropathol Commun; 2014 Jun; 2():59. PubMed ID: 24894482 [TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
14. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018 [TBL] [Abstract][Full Text] [Related]
15. Tenascin-C Function in Glioma: Immunomodulation and Beyond. Yalcin F; Dzaye O; Xia S Adv Exp Med Biol; 2020; 1272():149-172. PubMed ID: 32845507 [TBL] [Abstract][Full Text] [Related]
17. OLIG2 maintenance is not essential for diffuse intrinsic pontine glioma cell line growth but regulates tumor phenotypes. Liao Y; Luo Z; Deng Y; Zhang F; Rao R; Wang J; Xu L; Kumar SS; Sengupta S; DeWire-Schottmiller M; Berry K; Garrett M; Fouladi M; Drissi R; Lu QR Neuro Oncol; 2021 Jul; 23(7):1183-1196. PubMed ID: 33539525 [TBL] [Abstract][Full Text] [Related]
18. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Saratsis AM; Yadavilli S; Magge S; Rood BR; Perez J; Hill DA; Hwang E; Kilburn L; Packer RJ; Nazarian J Neuro Oncol; 2012 May; 14(5):547-60. PubMed ID: 22492959 [TBL] [Abstract][Full Text] [Related]
19. A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Hummel TR; Salloum R; Drissi R; Kumar S; Sobo M; Goldman S; Pai A; Leach J; Lane A; Pruitt D; Sutton M; Chow LM; Grimme L; Doughman R; Backus L; Miles L; Stevenson C; Fouladi M; DeWire M J Neurooncol; 2016 Mar; 127(1):53-61. PubMed ID: 26626490 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]